Baudic, Manon https://orcid.org/0000-0001-6414-5012
Murata, Hiroshige https://orcid.org/0000-0002-4627-7326
Bosada, Fernanda M.
Melo, Uirá Souto https://orcid.org/0000-0003-4065-8635
Aizawa, Takanori
Lindenbaum, Pierre https://orcid.org/0000-0003-0148-9787
van der Maarel, Lieve E. https://orcid.org/0000-0001-6686-4029
Guedon, Amaury
Baron, Estelle
Fremy, Enora
Foucal, Adrien
Ishikawa, Taisuke https://orcid.org/0000-0001-8195-4700
Ushinohama, Hiroya
Jurgens, Sean J. https://orcid.org/0000-0002-1605-9782
Choi, Seung Hoan https://orcid.org/0000-0002-2797-3190
Kyndt, Florence
Le Scouarnec, Solena
Wakker, Vincent
Thollet, Aurélie
Rajalu, Annabelle
Takaki, Tadashi
Ohno, Seiko https://orcid.org/0000-0003-1209-8896
Shimizu, Wataru
Horie, Minoru https://orcid.org/0000-0002-9029-2339
Kimura, Takeshi
Ellinor, Patrick T. https://orcid.org/0000-0002-2067-0533
Petit, Florence https://orcid.org/0000-0002-1368-1023
Dulac, Yves
Bru, Paul
Boland, Anne
Deleuze, Jean-François
Redon, Richard https://orcid.org/0000-0001-7751-2280
Le Marec, Hervé https://orcid.org/0000-0002-8288-8693
Le Tourneau, Thierry https://orcid.org/0000-0002-0110-9054
Gourraud, Jean-Baptiste
Yoshida, Yoshinori https://orcid.org/0000-0001-5511-9090
Makita, Naomasa https://orcid.org/0000-0002-1807-672X
Vieyres, Claude
Makiyama, Takeru
Mundlos, Stephan
Christoffels, Vincent M. https://orcid.org/0000-0003-4131-2636
Probst, Vincent
Schott, Jean-Jacques
Barc, Julien https://orcid.org/0000-0003-4106-5946
Funding for this research was provided by:
Agence Nationale de la Recherche (R21006NN, RPV21014NNA)
Article History
Received: 17 February 2023
Accepted: 8 April 2024
First Online: 20 April 2024
Competing interests
: Y.Yoshida owns stock in iPS Portal. Takeda Pharmaceutical Company Ltd. is paying the salary of T.T. independently of this work. P.T.E. has received sponsored research support from Bayer AG and IBM Health, and he has consulted for Bayer AG, Novartis and MyoKardia. The remaining authors declare no competing interests.